SYNGENE

SYNGENE futures closed at ₹389.50, +7.8% to spot, with 100% of open interest in the 30 Mar contract, and the 360 straddle prices a move of about ±11% by expiry.

0.00% of futures OI sits beyond the 30 Mar contract · 47 of 58 listed contracts traded · 7,700 option contracts changed hands

The 360 straddle closed at ₹39.40 (call 39.35 + put 0.05), pricing a move of about ±11% by the 30 Mar expiry. In the last 271 windows of 1 sessions, SYNGENE moved more than that 0 times.

Call OI, lots

4,40044 L shares

Put OI, lots

2,20022 L shares

Puts per call, by OI

0.50by volume 2.95

Max pain

440+22% from the close

Contracts traded

47 of 58listed for this expiry

After the last 1 bulletins, SYNGENE closed higher five sessions later in 0 of 1.

Revenue ₹736 cr; profit −₹9 cr in the Jun 2026 quarter, consolidated.

3.0 times book value, a 0.35% dividend yield, market cap ₹15,000 cr.

Market cap

₹15,000 cron 1 Oct · free float ₹6,900 cr

Price to earnings

—fewer than four consecutive quarters filed

Trailing EPS

—fewer than four consecutive quarters filed

Price to book

3.0consolidated · balance sheet to Mar 2026

Book value a share

₹119.88consolidated · balance sheet to Mar 2026 · over NSE's share count

Debt to equity

0.00borrowings over equity · consolidated · balance sheet to Mar 2026

Return on equity

—needs two filed balance sheets

Dividend yield

0.35%₹1.25 a share in 365 days

Face value

₹10a share

Shares outstanding

40 cron 1 Oct

Revenue, trailing 12 months

—fewer than four consecutive quarters filed

Revenue growth, 12 months

—needs eight consecutive quarters filed

Revenue 3-year CAGR

—needs twelve consecutive quarters filed

Profit, trailing 12 months

—fewer than four consecutive quarters filed

Profit growth, 12 months

—needs eight consecutive quarters filed

Profit 3-year CAGR

—needs twelve consecutive quarters filed

Promoters hold 52.6%, foreign portfolio investors 11.8%, mutual funds 25.8% and insurance companies 2.1%, as filed for the quarter to 30 Jun.

• Promoters 52.6%
• Foreign portfolio investors 11.8%
• Mutual funds 25.8%
• Insurance companies 2.1%
• Banks and financial institutions 0.1%
• Individual investors 6.5%
• Others 1.1%

Nothing upcoming on record; the last was a dividend of ₹1.25 a share, ex-date 25 Jun 2026.

SYNGENE is −9.4% over 20 sessions against Nifty's −6.2%, 47% below its 52-week high, realised volatility 24% annualised.

Average true range, 14

₹112.9% of the close

Average day's range, 20

₹9.12.5% of the close

Volume against 20 sessions

0.84×5.3 L vs 6.3 L average

Realised volatility, 20

24%≈ ±1.5% a session · moved more than that on 5 of 20

Realised volatility, 60

25%≈ ±1.6% a session · moved more than that on 18 of 60

Realised volatility, 250

32%≈ ±2.0% a session · moved more than that on 57 of 250

Beta to Nifty, 60

0.70moved with Nifty on 34 of 60 sessions

Beta to Nifty, 250

0.82moved with Nifty on 151 of 250 sessions

Last 20 sessions

5 up · 15 downof 20

Last 60 sessions

25 up · 34 downof 59

Last 250 sessions

108 up · 141 downof 249

Best session, 250

▲ +8.2%30 Apr

Worst session, 250

▼ −9.9%27 Jan

Company

Syngene International Limited

Exchange

NSE · BSE 539268, group A

Listed on NSE

11 Aug 2015

Classification

Healthcare › Healthcare Services › Healthcare Research, Analytics & Technology

Index

BSE 500

Face value

₹10 a share

ISIN

INE398R01022

Sessions on record

272

Price source

NSE UDiFF bhavcopy · end of day · delayed

Filings

NSE and BSE public disclosures · results, shareholding and corporate actions as filed

Computed

1 Oct, 10:08 pm IST

Bulletins

1 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.